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Background and Objectives: considering other pathological processes caused by viral 
infection and its impacts on affected children, it becomes relevant to identify aspects related to 
COVID-19 in pediatrics. In this regard, this study aimed to describe the clinical characteristics 
of pediatric admissions related to COVID-19 in a reference hospital in children’s health in the 
city of Manaus. Methods: this is an ecological and descriptive study based on admissions data. 
The analyzed variables were: number of hospitalizations of COVID-19; month of 
hospitalization; age group of patients (categorized as: less than 1 year; 1 to 4; 5 to 9; 10 to 14 
years); number of deaths; number of discharges, evasions or transfers; diagnostic method for 
COVID-19; mortality rate; number of atypical clinical manifestations; description of the 
manifestations. Results: thirty-five children diagnosed with COVID-19 were identified. 
Atypical manifestations are present in 20% of cases. There was a difference between the 
number of deaths and the number of discharges or transfers, with May presenting the highest 
number of cases. Conclusion: the study identified an increase in the frequency of 
hospitalization of children infected with COVID-19, raising an alert for a possible relationship 
between the disease and atypical manifestations, such as neurological disorders. The incipient 
scientific production, due to the recent history of the COVID-19 pandemic, reveals the need for 
further studies in the pediatric population as well as the development of measures to promote 
and monitor health and development in this population. 




Justificativa e Objetivos: considerando outros processos patológicos causados por infecção 






COVID-19 em pediatria. Nesse sentido, este estudo tem como objetivo descrever as 
características clínicas das internações pediátricas relacionadas à COVID-19 em hospital de 
referência em saúde infantil na cidade de Manaus. Métodos: estudo de caráter descritivo, 
baseado em dados de internações. As variáveis analisadas foram: número de internações de 
COVID-19; mês de internação; faixa etária dos pacientes (categorizadas em: menor de 1 ano; 
1 a 4; 5 a 9; 10 a 14 anos); número de óbitos; número de altas, evasões ou transferências; 
método diagnóstico para COVID-19; taxa de mortalidade; número de manifestações clínicas 
atípicas; descrição das manifestações. Resultados: foram identificadas 35 crianças 
diagnosticadas com COVID-19. Manifestações atípicas estiveram presentes em 20% dos casos. 
Houve diferença entre o número de óbitos e número de altas ou transferências, com o mês de 
maio apresentando o maior número de casos. Conclusão: o estudo identificou um aumento na 
frequência de internação de crianças infectadas por COVID-19, levantando um alerta para 
possível relação da doença com manifestações atípicas, como afecções neurológicas. A 
incipiente produção científica, devido ao recente histórico de pandemia por COVID-19, revela 
a necessidade de novos estudos na população pediátrica, assim como a elaboração de medidas 
de promoção e monitoramento de saúde e desenvolvimento nessa população. 




Justificación y Objetivos: considerando otros procesos patológicos provocados por la 
infección viral y su impacto en los niños afectados, cobra relevancia identificar aspectos 
relacionados con el COVID-19 en pediatría. En este sentido, este estudio tiene como objetivo 
describir las características clínicas de las hospitalizaciones pediátricas relacionadas con 
COVID-19 en un hospital de referencia para la salud infantil en la ciudad de Manaus. 
Métodos: estudio ecológico, de carácter descriptivo, basado en datos de hospitalización. Las 
variables analizadas fueron: número de hospitalizaciones por COVID-19; mes de 
hospitalización; rango de edad de los pacientes (categorizados como: menos de 1 año; 1 a 4; 
5 a 9; 10 a 14 años); número de muertes; número de alta, evasión o traslados; método de 
diagnóstico para COVID-19; tasa de mortalidad; número de manifestaciones clínicas atípicas; 
descripción de las manifestaciones. Resultados: se identificaron 35 niños diagnosticados con 
COVID-19. Las manifestaciones atípicas estuvieron presentes en el 20% de los casos. Hubo 
una diferencia entre el número de muertes y el número de altas o traslados, siendo el mes de 
mayo el que presentó el mayor número de casos. Conclusiones: el estudio identificó un 
aumento en la frecuencia de hospitalización de niños infectados por COVID-19 y alertó sobre 
una posible relación entre la enfermedad y manifestaciones atípicas, como trastornos 
neurológicos. La incipiente producción científica, debido a la historia reciente de la pandemia 
COVID-19, revela la necesidad de realizar más estudios en la población pediátrica, así como 
el desarrollo de medidas para promover y monitorear la salud y el desarrollo de esta población. 










In December 2019, the disease caused by the coronavirus 2 severe acute respiratory 
syndrome (Sars-CoV-2), COVID-19 (Coronavirus Disease 2019), was reported for the first 
time in the Chinese province of Wuhan. Since then, the number of infected cases has grown on 
a large scale and soon the disease was classified by the World Health Organization (WHO) as 
a public health emergency of international concern.1 
COVID-19 is a disease that evolves with clinical aspects ranging from asymptomatic 
conditions to severe acute respiratory infection. The diagnosis is hindered by the low specificity 
of symptoms in the initial phase, such as the absence of fever and radiological abnormalities. 
The WHO reports that most people will have mild respiratory symptoms, but the elderly 
population and those with associated conditions may develop more severe symptoms and need 
advanced support.2,3 
In children, the clinical manifestations are similar to those of adults. Some children 
progress with gastrointestinal symptoms, but generally the infection progresses from mild to 
moderate. In the first national-level epidemiological study aimed at the pediatric public, which 
assessed more than 2,000 children infected with COVID-19 in China, only 5.9% of cases were 
classified as serious and only one child died.4,5 
This same study also showed that infection with the new coronavirus did not show any 
significant difference between genders. Moreover, it showed that the majority of cases were 
mild infections and in the average age group of 7 years. However, children under five years of 
age were the most affected by severe and critical cases of the disease.5 
Another study that sought to analyze case series also showed that most infected children 
evolve with greater gastrointestinal symptoms compared to adults. Other associated 
impairments, such as neurological and genetic disorders, have not been reported.6 
Recent Brazilian data show that the frequency of hospitalization of children with 
respiratory symptoms in 2020 is lower compared to previous years. Despite this, the most up-
to-date regional epidemiological bulletins point to an increase in the number of children 
diagnosed with COVID-19 compared to the period of appearance of the first cases in Brazil. 
States such as São Paulo (SP), Amazonas (AM), Ceará (CE), Pernambuco (PE), and Amapá 
(AP) are important centers of the pandemic.7-10 
AM has a higher incidence and lethality rate than the national average, thus showing an 
expressive growth in the number of children infected by COVID-19. While SP maintains 






In view of this scenario, it is essential to understand the factors that led to this condition 
as well as to elucidate the evolution of cases of COVID-19 in children. Thus, the main objective 
of this study was to describe the profile of pediatric admissions related to COVID-19 in a 
reference hospital for children’s health in the city of Manaus, AM. 
 
METHODS 
This is an ecological, descriptive study, based on data from admissions linked to 
COVID-19 in a reference hospital for children’s health in the city of Manaus, AM, from March 
1 to May 20, 2020. Therefore, data from the COVID-19 Bulletin was published by the Center 
for Epidemiology and Hospital Infection Control of the institution, which has an installed 
capacity for hospital/outpatient assistance, with approximately 77 beds in orthopedics, general 
surgery, anesthesiology, and intensive care.12,13 
Such hospital unit is located in a region of the capital of Amazonas that is very affected 
by the disease, with an incidence greater than 200 per 100 thousand inhabitants. Besides, it is a 
strategic location close to the main airports of the city and the municipalities in the metropolitan 
region that access the city of Manaus via land transport.11 
The variables used for analysis were: number of COVID-19 hospitalizations; month of 
hospitalization; age group of hospitalized patients (categorized as: less than 1 year; 1 to 4; 5 to 
9; 10 to 14 years); number of deaths; number of discharges, evasions or transfers; diagnostic 
method for COVID-19; mortality rate; number of atypical clinical manifestations; description 
of the manifestations. 
The information obtained by the aforementioned Bulletin was accessed on May 21, 2020 
and converted into tables, using Microsoft Excel, version 16.1, in which descriptive statistical 
analysis was performed. The data were presented in the form of absolute numbers, frequency 
relative and 95% confidence interval (CI). As there was no access to individual data, it was not 
possible to calculate a point estimate (p value). Therefore, the interval estimate (95% CI) of the 
variables was used for statistical inference, with those categories without intersection between 
their 95% CI being considered significant differences. 
This study was carried out based on secondary data, with no access to nominal data of 
patients or any others that establish their identification. In this context, it was not necessary to 
submit to the Research Ethics Committee (REC), according to Resolution 466 of December 12, 








Between March and May 2020, a total of 35 children with a diagnosis of COVID-19 
were hospitalized. In general, a higher percentage of them started hospitalization in May, 
despite the shorter time (less days) compared to the other months (Figure 1), and with a 
predominance of the age group of 2 to 4 years. Most of them were transferred or discharged, 
and atypical clinical manifestations were present in sporadic cases (minority). 
 
 
Figure 1. Distribution of COVID-19 cases according to the month of hospitalization from March 1 to May 20 
 
Table 1 shows the frequency and CI of the number of pediatric patients hospitalized 
with COVID-19 in relation to the month of diagnosis, age group, hospital outcome (transfer, 
evasion, discharge, or death), diagnostic method, and clinical manifestations (present or 
absent). 
 









95% (CI 95%) 
Age group    
< 1 year 10  28.6 16.3 – 45.1 
2 to 4 years 11  31.4 18.6 – 48.0 
5 to 9 years 06  17.1 8.1 – 32.7 




















    
Hospital outcome    
Transfer 14  40.0 25.6 – 56.4 
Discharge 17  48.6 33.0 – 64.4 
Evasion 02  5.7 1.6 – 18.6 
Death 02  5.7 1.6 – 18.6 
    
Diagnostic method    
Rapid Test 19  54.3 38.2 – 69.5 
RT-PCR 16  45.7 30.5 – 61.8 
    
Atypical clinical manifestations    
Presents 07  20.0 10.0 – 35.9 
Absents 28  80.0 64.1 – 90.0 
*Atypical manifestations present: 01 case of meningitis; Seizure 01; 01 case of Guilliain Barré Syndrome; 01 case of acute 
diffuse glomerulonephritis; 01 case of Exanthematic Febrile Syndrome; 01 case of gastroenteritis; 01 case of nonspecific 
abdominal pain. 
  
Regarding the age groups of hospitalized patients, there was no statistical difference 
between the categories, although most children are up to 4 years old (21, equivalent to 60% of 
cases). The mortality rate for the cases studied was 5.7% (95% CI: 1.6% -18.6%), with a 
statistically significant difference between the number of deaths and the number of discharge 
or transfers, according to CI. The diagnostic methods did not differ in the sample; however, 
according to the source of information, it was not possible to know whether patients who were 
diagnosed using RT-PCR (Polymerase Transcriptase Reverse Chain Reaction) performed the 
rapid test or vice versa, which precludes a more complex analysis of diagnostic methods. 
Most children did not present atypical clinical manifestations, which was significant in 
relation to the absent cases. According to the data extraction document, of the seven children 
with atypical manifestations, three of them had neurological changes (8.6%), namely: 01 case 
of meningitis, 01 seizure, and 01 Guillain-Barré Syndrome. The remaining cases were (only 01 
patients each) acute diffuse glomerulonephritis, Exanthematic Febrile Syndrome, 
gastroenteritis, and nonspecific abdominal pain. 
 
DISCUSSION 
This study is one of the pioneers in the formal presentation and discussion of cases of 
children infected with COVID-19 in the Amazon region. In general, the results showed a 






and continuing through May, which may indicate a follow-up to the rising regional and national 
epidemiological curve and the total number of cases. In March and April, AM had a higher 
incidence of cases among the states in northern Brazil. Such a finding may fit the results of the 
research by Mendonça et al. (2020), which demonstrated that the highest frequency of 
hospitalizations due to respiratory diseases in northern states occurs from March to June due to 
climatic issues that involve a longer period rain and increased humidity, making the 
environment more favorable to viral transmissibility.8-11,15,16 
Huang and colleagues (2020) report that as the epidemic spread in China, the number 
of infected children has increased. However, differently from other Brazilian regions very 
affected by the pandemic, the findings of this research seem to show a disproportionate growth 
of the affections in the pediatric public in relation to the total of confirmed cases in this period, 
in Manaus, which may be related to the regional characteristics of frequency of admissions due 
to respiratory diseases.1,9-11 
In a study that sought to investigate the characteristics of children infected with COVID-
19 in Italy, which assessed data from 11 Italian pediatric hospitals, Garazzino and collaborators 
(2020) identified 168 cases until April, of which 110 were hospitalized. In the United States, 
between February and April 2020, of the total cases of COVID-19 infection confirmed by 
laboratory examination (almost 150,000), 1.7% (2,572) were of individuals under 18 years old. 
Such research did not present information capable of defining whether there was an increase in 
the frequency of infection in children over time.17-18 
The data found in this study show us that most patients admitted to the assessed unit 
were either transferred or discharged. The transfers of these children are probably not related 
to the need for care at a higher level of complexity, but to the fact that the hospital in the study 
was not defined by the state government as a reference to caring for patients infected with 
COVID-19. Furthermore, in a research that assessed the symptoms of the disease in the 
pediatric population, most of results conclude that the infection is mild to moderate, which 
contributes to clarifying the large number of hospital discharge found.17-19 
The infected children had two types of tests as a diagnostic method, the rapid test and 
the RT-PCR. The first is to detect antibodies against Sars-CoV-2 antigens. The second is the 
laboratory method for identifying the virus, being carried out by collecting respiratory material. 
According to data from the assessed institution, it does not have the necessary machinery to 
perform tomography, another test that may indicate a lung injury caused by infection with the 






children is difficult. Even so, there are no reports showing severe lung injury in the pediatric 
public due to COVID-19.2,20,21 
The mortality rate for the assessed cases was 5.7%, a number corresponding to the 
percentage of severe cases found in a Chinese cohort and equal to the number of patients who 
required hospitalization in the United States in the same period. The most recent national 
epidemiological bulletin shows that the mortality rate in cases of infection associated with 
COVID-19 in children was 15.3% in Brazil.5,18,20 
Clinical studies that sought to present clinical and epidemiological characteristics of 
COVID-19 infection reported that patients with severe cases and with a greater chance of 
having death as an outcome were not in the age group under 18 years old. The mortality rate is 
variable, and in the child population, it was between 0 and 3%. It is worth mentioning that the 
assessed sample by these surveys is greater than the study presented here. However, studies on 
COVID-19 manifestations are still incipient. Moreover, the number of cases is still on the rise, 
so it is not possible to predict whether the mortality rate will remain the same.2,5,17 
National study data seem to point to differences in the spread of the virus and a 
consequent increase in the number of cases of infection with respect to spatial and geographical 
characteristics. Findings from the Center for Disease Control in the United States also pointed 
to epidemiological differences arising from geographic variations. Official data on the epidemic 
in Brazil show that northern Brazil is the most affected and that the coefficient of incidence and 
mortality rate, in AM, are the highest. In this regard, a more stratified approach that includes 
more information about the profile of the pediatric population affected by COVID-19 is 
necessary and may assist in planning public policies, aimed at child growth and development 
as well as in health promotion.8,22,23 
Data from the study in question show that 20% of infected children had atypical 
manifestations (neurological changes, gastroenteritis, nonspecific abdominal pain, etc.). 
Children under 5 years old seem to have more episodes of vomiting and diarrhea. Although it 
is not possible to determine the age of patients who evolved with such clinical findings, more 
attention is needed to the age group under 5 years old, who had a higher frequency of 
hospitalization by the study. Such special attention is due not only to immunological issues, but 
also due to aspects of greater growth, development and maturation of the central nervous system 
related to this age group. That is, the higher the levels of exposure of agents potentially harmful 
to the development of these children the greater the chances of changes and impairments to 






considering that brain plasticity, in greater activity in children up to five years of age, is 
characterized by the ability to constantly remodel not only function, but also the structure of 
the brain, influenced by the experience that extends throughout life.5,17,24 
Besides that, investigating possible atypical manifestations, especially neurological, is 
of paramount importance due to the recent Brazilian history, linked to the Zika Virus (ZIKV) 
epidemic, identified in 2015. Such infection resulted in serious consequences for child 
development, characterized by the emergence of a congenital syndrome in which the main 
involvement was the microcephaly of children whose mothers were infected during pregnancy. 
After that, new strategies were needed to include supportive measures for this population in the 
health system.25 
The study has as a limitation the number of assessed children (35), which will require 
constant monitoring of the numbers and greater exploration of them, including analysis of 
individual variables. However, it is useful to describe data and assist in the adoption of criteria 
aimed at following-up these patients, on an outpatient basis and within the scope of primary 
care, to monitor possible changes linked to COVID-19 and to relate potential adverse events 
associated with the acute condition of the disease by the new coronavirus with special attention 
to possible neurological changes. 
In conclusion, the study identified an increase in the frequency of hospitalization of 
children infected with COVID-19 as well as the possibility, even if not certified, of a 
relationship between coronavirus infection and associated atypical factors. The incipient 
scientific production aimed specifically at the pediatric public affected by this disease, in 
addition to the recent history of complications in child development caused by maternal 
contamination by the Zika Virus, suggests the need to create measures to promote health and 
monitor this population with regard to strengthening Primary Health Care actions aiming at 
comprehensive and multidisciplinary care. 
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